Junli He - 21 Jul 2026 Form 4 Insider Report for Harvard Apparatus Regenerative Technology, Inc. (HRGN)

Reporting relationship: CEO, Director
Issuer ticker: HRGN
Reported as of: 21 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Aug 2026, 14:36:47 UTC
Prior SEC filing: 01 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Joseph Damasio, by power of attorney

Key filing fact

Junli He filed Form 4 for Harvard Apparatus Regenerative Technology, Inc. (HRGN) on 11 Aug 2026.

Key facts

This page summarizes Junli He's Form 4 filing for Harvard Apparatus Regenerative Technology, Inc. (HRGN).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 11 Aug 2026, 14:36.

Change

Previous filing in this sequence was filed on 01 Dec 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001728598 Primary reporting owner

He Junli

Relationship: CEO, Director
Address: C/O HREGEN, 84 OCTOBER HILL ROAD, SUITE 11, HOLLISTON
Signature: /s/ Joseph Damasio, by power of attorney
Signature date: 11 Aug 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HRGN transaction Derivative

Nonqualified Stock Option (right to buy), time-based tranche

Award

Transaction value
Shares: +600,000
Change %
Price: $0.000000^*
Shares after: 600,000
Date: 21 Jul 2026
Ownership: Direct
Underlying class: Common Stock, par value $0.01 per share
Underlying amount: 600,000
Exercise price: $1.09
Footnotes: F1

HRGN transaction Derivative

Nonqualified Stock Option (right to buy), performance-based

Award

Transaction value
Shares: +600,000
Change %
Price: $0.000000^*
Shares after: 600,000
Date: 21 Jul 2026
Ownership: Direct
Underlying class: Common Stock, par value $0.01 per share
Underlying amount: 600,000
Exercise price: $1.09
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Subject to the Reporting Person's continued employment through each applicable vesting date, the time-based portion of the nonqualified stock option vests and becomes exercisable as follows: 100,000 shares vest upon signing of the applicable award agreement, representing vesting for the six-month period from March 1, 2026 through August 31, 2026, subject to the Reporting Person's continued employment through the date of signing. Thereafter, 16,667 shares vest on the first day of each calendar month commencing September 1, 2026, subject to the Reporting Person's continued employment with the Issuer through each applicable vesting date; provided that the final monthly installment will be adjusted as necessary so that no more than 600,000 shares vest under the time-based tranche.

Footnote F2

Subject to the Reporting Person's continued employment through the applicable vesting date, the performance-based portion of the nonqualified stock option vests and becomes exercisable in four milestone tranches as follows: (i) 250,000 shares upon the closing of a sale of a controlling stake in the Issuer or the listing of its common stock on a national securities exchange (Nasdaq or NYSE), whichever occurs first, following the grant date; (ii) 125,000 shares if, at any time following the Issuer's initial public offering or the listing of its common stock on a national securities exchange, the volume-weighted average price of the Issuer's common stock equals or exceeds two times (2.0x) the initial public offering price or initial listing price, or such fixed target as may be established by the Compensation Committee, e.g., $3.00 per share, for twenty (20) consecutive trading days; (iii) 125,000 shares upon the first date on which the Issuer has raised at least an additional $10,000,000

SEC remarks

Upon the consummation of a Sale Event or the occurrence of a Change of Control, each as defined in the Issuer's Amended and Restated Equity Incentive Plan, the option becomes fully vested and exercisable with respect to all shares subject to the option. The reported option is a single nonqualified stock option covering 1,200,000 shares of the Issuer's common stock. The two Table II rows separately present the 600,000-share time-based portion and the 600,000-share performance-based portion because the portions have different vesting conditions.